Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Lysine Hydrochloride and Calcium Hydrogen Phosphate Granules

Approval Number

国药准字H22024961

Company吉林万通药业集团梅河药业股份有限公司

Registration Date

March 19, 2020

Drug Information

Generic Name

赖氨酸磷酸氢钙颗粒

Brand Name

万通

Dosage Form

颗粒剂

Strength

盐酸赖氨酸0.1g、磷酸氢钙0.1g

Drug Type

化学药品

Registration Date

March 19, 2020

Company Information

Applicant Company

Company Name吉林万通药业集团梅河药业股份有限公司

Manufacturing Company

Company Name吉林万通药业集团梅河药业股份有限公司

Company Address

吉林省梅河口市万通路666号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy